PUBLISHER: KBV Research | PRODUCT CODE: 1093326
PUBLISHER: KBV Research | PRODUCT CODE: 1093326
North America Exosome Diagnostic and Therapeutic Market Size, Share & Industry Trends Analysis Report By Application (Diagnostic and Therapeutic), By Product (Reagent, Instrument, and Software), By End User, By Country and Growth Forecast, 2022 - 2028
The North America Exosome Diagnostic and Therapeutic Market would witness market growth of 25.9% CAGR during the forecast period (2022-2028).
The rise in the prevalence of chronic disease, infectious disease, autoimmune disease, and cancer, as well as the spike in demand for molecular diagnosis, are driving the exosome diagnostic and therapeutic market. Furthermore, recent advancements in exosome technology in drug development and discovery provide vital information about heterogeneity and biological function, enhancing the possibility to leverage the therapeutic and diagnostic potential of exosomes in cancer and infectious disease. As a result, advancements in healthcare technology are propelling the growth of the exosome diagnostic and therapeutic market.
Exosomes derived from cow milk are being used to deliver therapeutic compounds to patients suffering from lung and breast cancer. Due to their tiny size, indigenous character, and capacity to traverse biological barriers, exosomes produced from specific body regions are intriguing candidates for anti-cancer vaccinations due to better passive targeting. As a result, as the number of cancer cases in hospitals rises, so will the demand for exosomes in diagnostics and therapies.
The North American region is one of the most flourishing exosome markets because of its strong healthcare infrastructure, effective government policies, a large base of multinational enterprises, and high public knowledge about diagnostics and healthcare. A huge number of government-funded research studies have been undertaken on the role of exosome-based medications in diseases such as melanoma, breast cancer, lung cancer, and pancreatic cancer, to name a few. Several colleges, including Yale University and Michigan State University, have financed and worked with companies like Merck and Exosome Diagnostic to perform clinical trials in the United States. Furthermore, government funding is very supportive of these projects. These will propel the North American exosome diagnostic and therapeutic market.
The US market dominated the North America Exosome Diagnostic and Therapeutic Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $391.1 million by 2028. The Canada market is anticipated to grow at a CAGR of 28.7% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 27.6% during (2022 - 2028).
Based on Application, the market is segmented into Diagnostic and Therapeutic. Based on Product, the market is segmented into Reagent, Instrument, and Software. Based on End User, the market is segmented into Cancer Institute, Hospital, Diagnostic Center, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bio-Techne Corporation, Qiagen N.V., Thermo Fisher Scientific, Inc., Aethlon Medical, Inc., Capricor Therapeutics, Inc., Malvern Panalytical Ltd., NanoSomix, Inc., System Biosciences, LLC, and NX Pharmagen, Inc.
Scope of the Study
Market Segments covered in the Report:
By Application
- Diagnostic
- Therapeutic
By Product
- Reagent
- Instrument
- Software
By End User
- Cancer Institute
- Hospital
- Diagnostic Center
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Companies Profiled
- Bio-Techne Corporation
- Qiagen N.V.
- Thermo Fisher Scientific, Inc.
- Aethlon Medical, Inc.
- Capricor Therapeutics, Inc.
- Malvern Panalytical Ltd.
- NanoSomix, Inc.
- System Biosciences, LLC
- NX Pharmagen, Inc.
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Exosome Diagnostic and Therapeutic Market, by Application
- 1.4.2 North America Exosome Diagnostic and Therapeutic Market, by Product
- 1.4.3 North America Exosome Diagnostic and Therapeutic Market, by End User
- 1.4.4 North America Exosome Diagnostic and Therapeutic Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition and Scenario
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. Strategies Deployed in Exosome Diagnostic and Therapeutic Market
Chapter 4. North America Exosome Diagnostic and Therapeutic Market by Application
- 4.1 North America Diagnostic Market by Country
- 4.2 North America Therapeutic Market by Country
Chapter 5. North America Exosome Diagnostic and Therapeutic Market by Product
- 5.1 North America Reagent Market by Country
- 5.2 North America Instrument Market by Country
- 5.3 North America Software Market by Country
Chapter 6. North America Exosome Diagnostic and Therapeutic Market by End User
- 6.1 North America Cancer Institute Market by Country
- 6.2 North America Hospital Market by Country
- 6.3 North America Diagnostic Center Market by Country
- 6.4 North America Others Market by Country
Chapter 7. North America Exosome Diagnostic and Therapeutic Market by Country
- 7.1 US Exosome Diagnostic and Therapeutic Market
- 7.1.1 US Exosome Diagnostic and Therapeutic Market by Application
- 7.1.2 US Exosome Diagnostic and Therapeutic Market by Product
- 7.1.3 US Exosome Diagnostic and Therapeutic Market by End User
- 7.2 Canada Exosome Diagnostic and Therapeutic Market
- 7.2.1 Canada Exosome Diagnostic and Therapeutic Market by Application
- 7.2.2 Canada Exosome Diagnostic and Therapeutic Market by Product
- 7.2.3 Canada Exosome Diagnostic and Therapeutic Market by End User
- 7.3 Mexico Exosome Diagnostic and Therapeutic Market
- 7.3.1 Mexico Exosome Diagnostic and Therapeutic Market by Application
- 7.3.2 Mexico Exosome Diagnostic and Therapeutic Market by Product
- 7.3.3 Mexico Exosome Diagnostic and Therapeutic Market by End User
- 7.4 Rest of North America Exosome Diagnostic and Therapeutic Market
- 7.4.1 Rest of North America Exosome Diagnostic and Therapeutic Market by Application
- 7.4.2 Rest of North America Exosome Diagnostic and Therapeutic Market by Product
- 7.4.3 Rest of North America Exosome Diagnostic and Therapeutic Market by End User
Chapter 8. Company Profiles
- 8.1 Bio-Techne Corporation (Exosome Diagnostic, Inc.)
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental and Regional Analysis
- 8.1.4 Research & Development Expense
- 8.1.5 Recent strategies and developments:
- 8.1.5.1 Partnerships, Collaborations, and Agreements:
- 8.2 Qiagen N.V.
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Regional Analysis
- 8.2.4 Research & Development Expense
- 8.3 Thermo Fisher Scientific, Inc.
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Segmental and Regional Analysis
- 8.3.4 Research & Development Expense
- 8.3.5 Recent strategies and developments:
- 8.3.5.1 Partnerships, Collaborations, and Agreements:
- 8.4 Aethlon Medical, Inc.
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Research & Development Expenses
- 8.5 Capricor Therapeutics, Inc.
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Research & Development Expenses
- 8.5.4 Recent strategies and developments:
- 8.5.4.1 Partnerships, Collaborations, and Agreements:
- 8.6 Malvern Panalytical Ltd. (Spectris plc)
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Segmental and Regional Analysis
- 8.6.4 Research & Development Expenses
- 8.7 Nanosomix, Inc.
- 8.7.1 Company Overview
- 8.8 System Biosciences, LLC
- 8.8.1 Company Overview
- 8.9 NX Pharmagen, Inc. (NX Prenatal, Inc.)
- 8.9.1 Company Overview
LIST OF TABLES
- TABLE 1 North America Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
- TABLE 2 North America Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
- TABLE 3 North America Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
- TABLE 4 North America Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
- TABLE 5 North America Diagnostic Market by Country, 2018 - 2021, USD Million
- TABLE 6 North America Diagnostic Market by Country, 2022 - 2028, USD Million
- TABLE 7 North America Therapeutic Market by Country, 2018 - 2021, USD Million
- TABLE 8 North America Therapeutic Market by Country, 2022 - 2028, USD Million
- TABLE 9 North America Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
- TABLE 10 North America Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
- TABLE 11 North America Reagent Market by Country, 2018 - 2021, USD Million
- TABLE 12 North America Reagent Market by Country, 2022 - 2028, USD Million
- TABLE 13 North America Instrument Market by Country, 2018 - 2021, USD Million
- TABLE 14 North America Instrument Market by Country, 2022 - 2028, USD Million
- TABLE 15 North America Software Market by Country, 2018 - 2021, USD Million
- TABLE 16 North America Software Market by Country, 2022 - 2028, USD Million
- TABLE 17 North America Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
- TABLE 18 North America Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
- TABLE 19 North America Cancer Institute Market by Country, 2018 - 2021, USD Million
- TABLE 20 North America Cancer Institute Market by Country, 2022 - 2028, USD Million
- TABLE 21 North America Hospital Market by Country, 2018 - 2021, USD Million
- TABLE 22 North America Hospital Market by Country, 2022 - 2028, USD Million
- TABLE 23 North America Diagnostic Center Market by Country, 2018 - 2021, USD Million
- TABLE 24 North America Diagnostic Center Market by Country, 2022 - 2028, USD Million
- TABLE 25 North America Others Market by Country, 2018 - 2021, USD Million
- TABLE 26 North America Others Market by Country, 2022 - 2028, USD Million
- TABLE 27 North America Exosome Diagnostic and Therapeutic Market by Country, 2018 - 2021, USD Million
- TABLE 28 North America Exosome Diagnostic and Therapeutic Market by Country, 2022 - 2028, USD Million
- TABLE 29 US Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
- TABLE 30 US Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
- TABLE 31 US Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
- TABLE 32 US Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
- TABLE 33 US Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
- TABLE 34 US Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
- TABLE 35 US Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
- TABLE 36 US Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
- TABLE 37 Canada Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
- TABLE 38 Canada Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
- TABLE 39 Canada Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
- TABLE 40 Canada Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
- TABLE 41 Canada Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
- TABLE 42 Canada Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
- TABLE 43 Canada Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
- TABLE 44 Canada Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
- TABLE 45 Mexico Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
- TABLE 46 Mexico Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
- TABLE 47 Mexico Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
- TABLE 48 Mexico Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
- TABLE 49 Mexico Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
- TABLE 50 Mexico Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
- TABLE 51 Mexico Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
- TABLE 52 Mexico Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
- TABLE 53 Rest of North America Exosome Diagnostic and Therapeutic Market, 2018 - 2021, USD Million
- TABLE 54 Rest of North America Exosome Diagnostic and Therapeutic Market, 2022 - 2028, USD Million
- TABLE 55 Rest of North America Exosome Diagnostic and Therapeutic Market by Application, 2018 - 2021, USD Million
- TABLE 56 Rest of North America Exosome Diagnostic and Therapeutic Market by Application, 2022 - 2028, USD Million
- TABLE 57 Rest of North America Exosome Diagnostic and Therapeutic Market by Product, 2018 - 2021, USD Million
- TABLE 58 Rest of North America Exosome Diagnostic and Therapeutic Market by Product, 2022 - 2028, USD Million
- TABLE 59 Rest of North America Exosome Diagnostic and Therapeutic Market by End User, 2018 - 2021, USD Million
- TABLE 60 Rest of North America Exosome Diagnostic and Therapeutic Market by End User, 2022 - 2028, USD Million
- TABLE 61 key information - Bio-Techne Corporation
- TABLE 62 Key Information - Qiagen N.V.
- TABLE 63 Key Information - Thermo Fisher Scientific, Inc.
- TABLE 64 Key Information - Aethlon Medical, Inc.
- TABLE 65 Key Information - Capricor Therapeutics, Inc.
- TABLE 66 Key Information - Malvern Panalytical Ltd
- TABLE 67 Key Information - Nanosomix, Inc.
- TABLE 68 Key Information - System Biosciences, LLC
- TABLE 69 Key Information - NX Pharmagen, Inc.
List of Figures
- FIG 1 Methodology for the research
